The New Biology
Queen Mary Studies in Intellectual Property series
Edited by Matthew Rimmer and Alison McLennan
This collection is part of the Queen Mary Studies in Intellectual Property series published by Edward Elgar. We were invited by Professor Graham Dutﬁeld to edit a collection on intellectual property and emerging technologies in the life sciences. Having explored gene patents and stem cell patents in our research, we were particularly keen to explore new challenges posed by paradigm shifts in biology. In 2009, the National Research Council of the National Academies deployed the term ‘New Biology’ to capture the convergence and integration of the various disciplines of biology: The essence of the New Biology, as deﬁned by the committee, is integration – re-integration of the many sub-disciplines of biology, and the integration into biology of physicists, chemists, computer scientists, engineers, and mathematicians to create a research community with the capacity to tackle a broad range of scientiﬁc and societal problems. Integrating knowledge from many disciplines will permit deeper understanding of biological systems, which will both lead to biology-based solutions to societal problems and also feed back to enrich the individual scientiﬁc disciplines that contribute new insights.1 We invited a number of the pre-eminent researchers and scholars to explore future trends and developments in a cluster of emerging scientiﬁc disciplines – including biodiscovery, genomics, medicine, bioinformatics, synthetic biology, RNA interference, stem cell research, nanotechnology, traditional knowledge, genetically modiﬁed crops, and clean technologies. Given the interdisciplinary nature of the topic, the contributors are drawn from an array of ﬁelds. Moreover, given the international, collaborative nature of...